Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses:
SEC Accession No. 0001193125-19-104620
Filing Date
2019-04-12
Accepted
2019-04-12 09:05:55
Documents
2

Document Format Files

Seq Description Document Type Size
1 FWP d679106dfwp.htm FWP 15748
2 GRAPHIC g679106g0412105457160.jpg GRAPHIC 3805
  Complete submission text file 0001193125-19-104620.txt   22974
Mailing Address 955 MASSACHUSETTS AVENUE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 955 MASSACHUSETTS AVENUE 4TH FLOOR CAMBRIDGE MA 02139 857-529-8300
X4 Pharmaceuticals, Inc (Filed by) CIK: 0001501697 (see all company filings)

EIN.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: FWP
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 955 MASSACHUSETTS AVENUE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 955 MASSACHUSETTS AVENUE 4TH FLOOR CAMBRIDGE MA 02139 857-529-8300
X4 Pharmaceuticals, Inc (Subject) CIK: 0001501697 (see all company filings)

EIN.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: FWP | Act: 34 | File No.: 333-229377 | Film No.: 19745323
SIC: 2836 Biological Products, (No Diagnostic Substances)